22.91
0.66 (2.94%)
| Previous Close | 22.26 |
| Open | 22.38 |
| Volume | 437,645 |
| Avg. Volume (3M) | 2,131,224 |
| Market Cap | 2,110,519,552 |
| Price / Earnings (TTM) | 11.23 |
| Price / Earnings (Forward) | 9.53 |
| Price / Sales | 0.610 |
| Price / Book | 0.640 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2025 |
| Profit Margin | 5.94% |
| Operating Margin (TTM) | 10.19% |
| Diluted EPS (TTM) | 2.04 |
| Quarterly Revenue Growth (YOY) | 0.30% |
| Quarterly Earnings Growth (YOY) | -89.00% |
| Total Debt/Equity (MRQ) | 74.09% |
| Current Ratio (MRQ) | 1.35 |
| Operating Cash Flow (TTM) | 462.46 M |
| Levered Free Cash Flow (TTM) | -276.20 M |
| Return on Assets (TTM) | 5.06% |
| Return on Equity (TTM) | 6.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Bearish |
| Medical Care Facilities (Global) | Mixed | Bearish | |
| Stock | Acadia Healthcare Company, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -4.0 |
| Average | -1.38 |
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.75% |
| % Held by Institutions | 109.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| P2 Capital Partners, Llc | 31 Mar 2025 | 2,142,188 |
| Abrams Bison Investments, Llc | 31 Mar 2025 | 1,820,000 |
| Khrom Capital Management Llc | 31 Mar 2025 | 1,587,299 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 31.00 (UBS, 35.31%) | Buy |
| Median | 27.00 (17.85%) | |
| Low | 20.00 (Barclays, -12.70%) | Hold |
| Average | 26.00 (13.49%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 19.45 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Mizuho | 14 Aug 2025 | 22.00 (-3.97%) | Hold | 20.66 |
| Raymond James | 14 Aug 2025 | 26.00 (13.49%) | Buy | 20.66 |
| RBC Capital | 13 Aug 2025 | 28.00 (22.22%) | Buy | 20.77 |
| Barclays | 07 Aug 2025 | 20.00 (-12.70%) | Hold | 18.20 |
| Guggenheim | 07 Aug 2025 | 29.00 (26.58%) | Buy | 18.20 |
| UBS | 07 Aug 2025 | 31.00 (35.31%) | Buy | 18.20 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Aug 2025 | Announcement | Acadia Healthcare Reports Second Quarter 2025 Results |
| 18 Jul 2025 | Announcement | Acadia Healthcare Announces Date for Second Quarter 2025 Earnings Release |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |